A consensus of scientists, a spectrum that follows the sun, and the metric that keeps getting in the way
In 2019 the lighting designer and physician Martin Moore-Ede did something the field had not managed in thirty years of argument: he asked the scientists to agree. He surveyed nearly two hundred and fifty of the leading researchers on light and circadian health and pressed them, statement by statement, toward consensus — and reached it on a set of propositions about what healthy light actually requires. The result was not another opinion. It was a published, peer-reviewed agreement among the people who know the evidence best.
That consensus is the foundation of this final module. The previous four built the problem: light is a signal, blue tells time, the body is an orchestra of clocks, and the wrong light at the wrong time carries real risk. This module turns all of that into a design brief. The encouraging news is that the brief is simple to state. The frustrating news is that almost nothing you can buy in a shop today meets it.
Walk the lighting aisle of any hardware store and you will find an enormous variety of bulbs that are, underneath, almost all the same thing: blue-pump LEDs. They are sold by “colour temperature” — a warm 2700K, a cool 5000K — as though that number told you whether the light was healthy. It does not. Even a warm-looking LED carries a spike of blue, and the warm tint is cosmetic: it changes how the light looks without removing the blue that the body reads as daytime.
So the market offers light that is, for circadian purposes, backwards: too little blue by day to signal “morning” strongly, and far too much blue in the evening to allow “night.” The consensus points to the fix. Healthy light is not about making everything dim or warm-tinted; it is about engineering the spectrum so that daytime light is genuinely blue-rich and bright, while evening and night light is genuinely depleted of blue. The science is settled enough to design around. What is missing is the will, the metrics, and the products.
Throughout this series the warning has been to distinguish a vivid study from the weight of evidence. The consensus survey is the weight of evidence made explicit: not one researcher's claim but a structured agreement among the field's leaders, published and citable. It is the strongest possible footing for moving from “here is the problem” to “here is what to do.”
Follow the move from diagnosis to design.
Measure the right thing. Stop asking a bulb's colour temperature and start asking its blue content — how much energy it puts out in the circadian-sensitive band around 480 nanometres. Two bulbs of identical “warmth” can suppress melatonin very differently. Blue content, not CCT, is the health-relevant number.
Engineer the spectrum. Once you measure blue content, you can engineer it. Daytime light can be built bright and blue-rich to anchor the clock; evening light can be built with the blue deliberately removed, not merely tinted over. This is spectral engineering: shaping the curve of energy across wavelengths to serve biology, rather than just hitting a brightness and a tint.
Write the day–night prescription. The shape of healthy light over a day is now clear: bright, blue-rich light in the morning and through the working day; a gradual withdrawal of blue in the evening; dim, blue-depleted, ideally amber light at night. It is the natural pattern of the sun, reconstructed indoors with intent.
Fix the metric that fights you. Here the design runs into an obstacle. Energy-efficiency rules reward lumens per watt — and the cheapest way to push that number up is to add blue, because the eye is most efficient near green-blue in daytime vision. So the regulations that were meant to save energy quietly mandate the very blue spike that harms circadian health. The metric must be revised, or healthy light will keep losing to efficient light.
Personalise, and claim the right. Finally, the prescription is not one-size-fits-all — sensitivity to light varies with age, chronotype and circumstance — and people cannot follow a prescription with products that do not exist. The closing argument is therefore both technical and civic: build personalisable circadian lighting, and recognise a right to healthy light as a public-health matter, the way we recognise rights to clean air and water.
Notice three things. One: the fix is a matter of spectrum and timing, not of dimming everything or fearing light. Two: the chief obstacle is not scientific but metrical and commercial — an efficiency rule pulling against a health goal. Three: the series closes on a recommendation, and recommendations carry their own confidence level — lower than settled mechanism, which is exactly why the consensus survey, not any single voice, is the warrant.
Colour temperature (CCT) describes how warm or cool a light looks; it does not reliably tell you how much circadian-active blue it emits. Two bulbs labelled the same warm 2700K can differ substantially in their melatonin-suppressing blue. The health-relevant measurement is the energy in the blue band the ipRGCs respond to, around 480 nm. Replacing “what colour temperature?” with “how much blue?” is the first and most important conceptual correction.
Where: on the bulb's label — in the number we ought to be reading instead of the one printed there now.
Once blue content is the target, light becomes something to shape. Spectral engineering means designing the full curve of emitted energy across wavelengths — boosting blue for daytime, removing it (not merely tinting over it) for night — rather than settling for a brightness and a tint. It is the technical heart of the solution and distinguishes genuinely circadian lighting from a warm-looking LED that still carries its blue spike.
Where: in the design of the light source itself — the LED phosphor mix, the diode choices, the tunable channels.
The therapeutic shape of light across a day: bright and blue-rich in the morning and through the working day to anchor the clock at high amplitude; blue gradually withdrawn in the evening; dim and blue-depleted, ideally amber, at night. It is the entire series in one sentence — the sun's natural arc, reconstructed indoors. Every earlier module is a reason this prescription is shaped the way it is.
Where: across the 24-hour day — in the schedule of light a well-designed building or home would deliver.
Lumens per watt — the standard efficiency metric — rewards exactly the blue-heavy spectra that harm circadian health, because the daytime eye is most efficient near blue-green. Efficiency mandates therefore push manufacturers toward the blue spike. This is the constraint that holds the whole solution back: not ignorance, but a regulatory and commercial incentive pointing the wrong way. Until the metric accounts for spectrum and timing, healthy light will keep losing to “efficient” light.
Where: in the efficiency standards and energy regulations that govern what manufacturers are rewarded for building — the constraint working against the prescription.
Sensitivity to light varies — with age (older eyes transmit less blue), with chronotype, with health and circumstance — so the prescription must be adjustable rather than fixed. And because people cannot follow a prescription with products that do not exist, the final claim is civic: access to healthy light is a public-health concern, comparable to clean air and water, and people have a right to it. Personalisation is the technical half; the right to healthy light is the political half.
Where: in the individual's own circadian needs, and in the public policy that decides whether healthy light is available to them at all.
In Pask's Conversation Theory, understanding means being able to reproduce a topic — to teach it back, derive it, and follow its why-paths. Here is the dependency structure for the whole solution.
Why these arrows. You cannot engineer a spectrum (B) until you measure the right quantity — blue content rather than colour temperature (A → B). Spectral engineering in turn makes the day–night prescription possible (B → C). The metric problem (D) is drawn as the dashed, limiting node: it constrains the integration directly, because the efficiency rule pushes against the very design the prescription calls for. Personalisation and the right to healthy light (E) feed the integration as the human and civic completion. The integration — bright blue by day, blue-depleted by night — is the entire series resolved into a single, actionable shape.
Serialist: A → B → C → D → E → integration. Measure blue, engineer the spectrum, write the prescription, confront the metric that fights it, then personalise and claim the right.
Holist: Start at the integration — bright blue by day, blue-depleted by night — and ask backwards: what must be true to deliver it? A health-relevant measurement, the engineering to shape light, a clear prescription, a metric that does not sabotage it, and access for everyone who needs it.
What a good answer reproduces: Colour temperature describes appearance, not circadian impact. A warm-looking LED can still emit a significant spike of blue around 480 nm, which is what suppresses melatonin. “Warm” tints the light without necessarily removing the blue. A good answer distinguishes how light looks from how much circadian-active blue it emits, and points to blue content as the number that matters.
What a good answer reproduces: Efficiency is measured in lumens per watt, and the daytime eye is most sensitive near blue-green, so adding blue is the cheapest way to raise the lumens-per-watt figure. Rules that mandate high efficiency therefore implicitly push manufacturers toward blue-heavy spectra — the very light that disrupts circadian health at night. A good answer shows the conflict is structural: a well-meant metric optimising the wrong variable, not a conspiracy.
What a good answer reproduces: Dimming reduces total intensity but leaves the spectrum's shape unchanged — a dimmed blue-rich light still delivers blue. Removing the blue changes the spectrum so that even at usable brightness the circadian signal is absent. The prescription wants evening light you can still see by that does not tell the clock “day.” A good answer separates intensity (how much) from spectrum (what wavelengths) and shows the prescription operates chiefly on the latter.
What a good answer reproduces: (1) Light is a signal whose effect depends on its wavelength, and the same photons do different biological work. (2) Blue light, for deep evolutionary reasons, is how the body reads the time of day. (3) That signal entrains an orchestra of cellular clocks whose synchrony is health. (4) The wrong light at the wrong time suppresses melatonin and, over years, raises real disease risk. (5) The remedy is to engineer light by its blue content into a day–night prescription — bright blue by day, blue-depleted by night. A good answer preserves the dependency: each sentence is a reason the next one matters.
What a good answer reproduces: A good answer identifies a setting where light is held constant and circadian-hostile — for example a hospital where patients get dim days and light-flooded nights — and rewrites it: bright, blue-rich light during the day to anchor the clock, blue-depleted amber light at night for necessary tasks. For elderly care it would note that ageing eyes transmit less blue, so daytime light must be brighter still (the personalisation point, E). The transfer shows the prescription is a general design tool, not a single product.
What this challenge is for: Pask's meta-conversation, closing the series. The receptor biology of Module Two is settled mechanism; the design recommendations here rest on a mixture of that settled science, the interpretive cancer evidence of Module Four, and an expert consensus about what to do given uncertainty. A recommendation inherits the confidence of its weakest necessary premise. A learner who finishes the series able to say “the mechanism is firm, the disease effect sizes are still being measured, and the prescription is the best current expert judgement” has learned the thing worth keeping: how to calibrate belief to the kind of claim being made — which outlasts every particular fact about light.
The series closes here — but the entailment opens outward. The pattern you have followed in light is the pattern of regulation in any living system: a signal, a receptor, a distributed set of clocks, a failure mode when the signal is wrong, and a design that restores the right signal at the right time. It is the same shape that the cybernetics, regeneration and quantum-biology series trace in other domains, and the same shape that groundregulation.com follows from the connective tissue of the body to the connective tissue of organisations.
Toward your own light. The most useful next step is empirical: measure the light you actually live in. A free phone app and a few readings — at your desk, by a window, in your evening rooms — will show you, often startlingly, how far your daily light is from the prescription. The series has given you the structure; your own environment is where it becomes real.
Explore further